Written by 2:48 pm Source News Views: 0

Small Business Innovation Research Program – Health.mil

Click to share the News

Defense Health Agency Celebrates 10 Years of Mission Readiness: ‘We Make a Difference’
“While we are young, we are mighty. We are important, and we make a difference,” said U.S. Army Lt. Gen. Telita Crosland, DHA director, celebrating the agency’s 10th anniversary.
This website has recently undergone changes. Users finding unexpected concerns may care to clear their browser’s cache to ensure a seamless experience.
The Defense Health Agency SBIR and STTR Programs are congressionally mandated programs established to increase the participation of small businesses in federal research and development. These programs enable DHA to spark the development of future technologies to improve warfighter health and survival. By tapping into the creativity of the small business community, the DHA SBIR/STTR Programs support U.S. small businesses in developing high-risk, high-impact medical materiel technologies with potential for wider commercialization. Under its SBIR Program, DHA seeks proposals from small businesses that respond to specific topics provided in the funding announcement. The smaller DHA STTR Program requires participation by research institutions.
The SBIR Program conducts a project, if successful, through three phases. Proposals submitted in response to the solicitation topics are competitively selected for Phase I awards. Note that Phase I is the entry point to the program; it cannot be bypassed. Phase I proposals must respond to a specific topic in the solicitation; the SBIR Program does not accept unsolicited proposals.
Phase I is the entry point to the three-phase program. In this phase, awards of $250,000 are provided for a 6-month period. In Phase I, the small business performer must prove the scientific, technical and commercial merit and feasibility of its concept.
All Phase I small business performers may compete for Phase II funding by submitting proposals near the end of Phase I. Phase II involves research, development, and demonstration of the most promising Phase I projects and is intended to produce a dualuse prototype product or service that meets the requirements of the original funding announcement topic. DHA SBIR/STTR Phase II efforts can be awarded up to a maximum of $1.3 million for a 24-month period. In addition, DHA Phase II Enhancements of up to $650,000 are available with a qualified 1-to-1 Phase III investment match. 
Phase III refers to work that derives from, extends, or completes an effort made under prior SBIR/STTR funding agreements, but is funded by sources other than the DHA SBIR or STTR Programs. Phase III work is typically oriented toward commercialization of SBIR- or STTR funded research or technology.
Frequently Asked Questions associated with the DHA SBIR/STTR Programs
Leadership Overview of the DHA SBIR STTR Programs
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.


(Visited 1 times, 1 visits today)